Predictive factors of stable deep molecular response in chronic phase CML patients treated with dasatinib or nilotinib after imatinib failure

This article has no abstract
Epistemonikos ID: a60622d8390614e69d842db9a0936b52e27392c4
First added on: Feb 08, 2025